return2ozma@lemmy.world to News@lemmy.world · 17 days agoVenus Williams Admits She Came Back to Tennis at Age 45 for the Health Insurancepeople.comexternal-linkmessage-square23linkfedilinkarrow-up1199arrow-down14cross-posted to: [email protected]
arrow-up1195arrow-down1external-linkVenus Williams Admits She Came Back to Tennis at Age 45 for the Health Insurancepeople.comreturn2ozma@lemmy.world to News@lemmy.world · 17 days agomessage-square23linkfedilinkcross-posted to: [email protected]
minus-squareTollana1234567@lemmy.todaylinkfedilinkarrow-up8·17 days agoi assume it will be biologic medication to treat her autoimmune and the news ones are quite expensive.
minus-squareShaggySnacks@lemmy.myserv.onelinkfedilinkEnglisharrow-up2·16 days ago i assume it will be biologic medication to treat her autoimmune and the news ones are quite expensive. From Why Biologics and Biosimilars Remain So Expensive: Despite Two Wins for Biosimilars, the Supreme Court’s Recent Rulings do not Solve Fundamental Barriers to Competition: Yet they are extremely expensive, costing on average $10,000-$30,000 per year and exceed $500,000 for the most expensive biologics. Millions of dollars don’t matter when you have to buy medication or constantly go to the doctor. These costs can add up fast.
i assume it will be biologic medication to treat her autoimmune and the news ones are quite expensive.
From Why Biologics and Biosimilars Remain So Expensive: Despite Two Wins for Biosimilars, the Supreme Court’s Recent Rulings do not Solve Fundamental Barriers to Competition:
Millions of dollars don’t matter when you have to buy medication or constantly go to the doctor. These costs can add up fast.